KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
OTCMKTS:AOLS
Delisted

Aeolus Pharmaceuticals, Inc Stock Insider Trading

OTC Markets Group > Healthcare > Drug Manufacturers—Specialty & Generic
Open Broker Account
$0.0001
+0 (+0%)
At Close: Nov 10, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile
Date Action Amount Person Type
Dec 28, 2016 Buy 25 000 Mcmanus John L Common Stock
Mar 04, 2016 Buy 250 000 Mcmanus John L Incentive Stock Option (right to buy)
Oct 01, 2015 Buy 100 000 Kumar Amit Non-qualified Stock Option (right to buy)
Mar 04, 2015 Buy 250 000 Mcmanus John L Incentive Stock Option (right to buy)
Oct 01, 2014 Buy 100 000 Kumar Amit Non-qualified Stock Option (right to buy)
Mar 04, 2014 Buy 250 000 Mcmanus John L Incentive Stock Option (right to buy)
Oct 01, 2013 Buy 100 000 Kumar Amit Non-qualified Stock Option (right to buy)
May 08, 2013 Buy 75 000 Cavalier David Non-qualified Stock Option (right to buy)
May 08, 2013 Buy 75 000 Suzdak Peter David Non-qualified Stock Option (right to buy)
May 08, 2013 Buy 75 000 Lewis Michael E Non-qualified Stock Option (right to buy)
May 08, 2013 Buy 100 000 Kumar Amit Non-qualified Stock Option (right to buy)
Mar 08, 2013 Buy 150 000 Skibsted Russell Non-qualified Stock Option (right to buy)
Mar 06, 2013 Buy 10 000 Mcmanus John L Common Stock
Mar 04, 2013 Buy 2 000 000 Mcmanus John L Non-qualified Stock Option (right to buy)
Feb 12, 2013 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Dec 27, 2012 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Oct 09, 2012 Buy 11 250 Lewis Michael E Non-qualified Stock Option (right to buy)
Oct 09, 2012 Buy 11 250 Kumar Amit Non-qualified Stock Option (right to buy)
Oct 09, 2012 Buy 11 250 Suzdak Peter David Non-qualified Stock Option (right to buy)
Aug 13, 2012 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Jul 14, 2012 Buy 250 000 Mcmanus John L Non-qualified Stock Option (right to buy)
Jul 11, 2012 Buy 11 250 Lewis Michael E Non-qualified Stock Option (right to buy)
Jul 11, 2012 Buy 11 250 Kumar Amit Non-qualified Stock Option (right to buy)
Jul 11, 2012 Buy 11 250 Suzdak Peter David Non-qualified Stock Option (right to buy)
May 23, 2012 Buy 7 027 Skibsted Russell Common Stock
Mar 20, 2012 Buy 11 250 Kumar Amit Non-qualified Stock Option (right to buy)
Mar 20, 2012 Buy 11 250 Suzdak Peter David Non-qualified Stock Option (right to buy)
Feb 10, 2012 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Dec 14, 2011 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Nov 07, 2011 Buy 11 250 Lewis Michael E Non-qualified Stock Option (right to buy)
Nov 07, 2011 Buy 11 250 Kumar Amit Non-qualified Stock Option (right to buy)
Nov 07, 2011 Buy 11 250 Suzdak Peter David Non-qualified Stock Option (right to buy)
Aug 11, 2011 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Jul 21, 2011 Buy 11 250 Lewis Michael E Non-qualified Stock Option (right to buy)
Jul 21, 2011 Buy 11 250 Kumar Amit Non-qualified Stock Option (right to buy)
Jul 21, 2011 Buy 11 250 Suzdak Peter David Non-qualified Stock Option (right to buy)
Jul 14, 2011 Buy 250 000 Mcmanus John L Non-qualified Stock Option (right to buy)
Jun 13, 2011 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
May 24, 2011 Buy 300 Mcmanus John L Common Stock
May 24, 2011 Buy 10 000 Mcmanus John L Common Stock
May 18, 2011 Buy 10 000 Mcmanus John L Common Stock
May 18, 2011 Buy 10 000 Mcmanus John L Common Stock
May 18, 2011 Buy 5 000 Skibsted Russell Common Stock
May 18, 2011 Buy 10 000 Skibsted Russell Common Stock
May 18, 2011 Buy 5 000 Skibsted Russell Common Stock
Apr 13, 2011 Buy 11 250 Lewis Michael E Non-qualified Stock Option (right to buy)
Apr 13, 2011 Buy 11 250 Kumar Amit Non-qualified Stock Option (right to buy)
Apr 13, 2011 Buy 11 250 Suzdak Peter David Non-qualified Stock Option (right to buy)
Mar 16, 2011 Sell 3 799 380 Efficacy Capital, Ltd. Common Stock
Mar 16, 2011 Sell 2 541 000 Efficacy Capital, Ltd. Common Stock Purchase Warrants (Right to Buy)
Mar 15, 2011 Sell 193 234 Efficacy Capital, Ltd. Common Stock
Mar 15, 2011 Buy 10 000 Mcmanus John L Common Stock
Feb 16, 2011 Sell 882 488 Cavalier David Common Stock, $0.01 par value per share
Feb 16, 2011 Sell 57 600 Efficacy Capital, Ltd. Common Stock
Feb 15, 2011 Buy 360 000 Skibsted Russell Non-Qualified Stock Option (right to buy)
Feb 15, 2011 Sell 7 000 Efficacy Capital, Ltd. Common Stock
Feb 10, 2011 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Feb 08, 2011 Sell 776 904 Efficacy Capital, Ltd. Common Stock
Feb 08, 2011 Sell 604 258 Efficacy Capital, Ltd. Common Stock Warrants (Right to Buy)
Jan 19, 2011 Buy 11 250 Lewis Michael E Non-Qualified Stock Option (right to buy)
Jan 19, 2011 Buy 11 250 Kumar Amit Non-Qualified Stock Option (right to buy)
Jan 19, 2011 Buy 11 250 Suzdak Peter David Non-Qualified Stock Option (right to buy)
Jan 06, 2011 Sell 616 450 Efficacy Capital, Ltd. Common Stock
Jan 06, 2011 Sell 479 461 Efficacy Capital, Ltd. Common Stock Warrants (Right to Buy)
Dec 28, 2010 Buy 3 750 Kumar Amit Non-qualified Stock Option (right to buy)
Dec 28, 2010 Buy 2 500 000 Cavalier David Common Stock, $0.01 par value per share
Dec 28, 2010 Buy 2 500 000 Cavalier David Warrants (right to buy)
Dec 28, 2010 Sell 2 500 000 Cavalier David Call Option (right to buy)
Dec 28, 2010 Sell 2 500 000 Cavalier David Put Option (obligation to buy)
Dec 15, 2010 Buy 11 250 Kumar Amit Non-Qualified Stock Option (right to buy)
Dec 15, 2010 Buy 11 250 Lewis Michael E Non-Qualified Stock Option (right to buy)
Nov 12, 2010 Buy 11 250 Kumar Amit Non-Qualified Stock Option (right to buy)
Nov 12, 2010 Buy 11 250 Lewis Michael E Non-Qualified Stock Option (right to buy)
Nov 12, 2010 Buy 11 250 Suzdak Peter David Non-Qualified Stock Option (right to buy)
Aug 11, 2010 Buy 3 750 Kumar Amit Non-Qualified Stock Option (right to buy)
Aug 11, 2010 Buy 2 500 000 Cavalier David Common Stock, par value $0.01 per share
Aug 11, 2010 Buy 250 000 Cavalier David Warrants (right to buy)
Aug 11, 2010 Buy 2 500 000 Cavalier David Call Option (right to buy)
Aug 11, 2010 Sell 2 500 000 Cavalier David Put Option (obligation to buy)
Jul 30, 2010 Buy 5 892 857 Cavalier David Common Stock, par value $0.01 per share
Jul 30, 2010 Buy 11 785 714 Cavalier David Warrants (right to buy)
Jul 29, 2010 Buy 11 250 Lewis Michael E Non-Qualified Stock Option (right to buy)
Jul 29, 2010 Buy 11 250 Kumar Amit Non-Qualified Stock Option (right to buy)
Jul 29, 2010 Buy 11 250 Suzdak Peter David Non-Qualified Stock Option (right to buy)
Jul 29, 2010 Buy 1 500 000 Mcmanus John L Incentive Stock Option
Jul 14, 2010 Buy 250 000 Mcmanus John L Non-qualified Stock Option (right to buy)
May 12, 2010 Buy 3 750 Kumar Amit Non-Qualified Stock Option (right to buy)
Apr 28, 2010 Buy 11 250 Lewis Michael E Non-Qualified Stock Option (right to buy)
Apr 28, 2010 Buy 11 250 Kumar Amit Non-Qualified Stock Option (right to buy)
Apr 15, 2010 Buy 10 000 Mcmanus John L Common Stock
Feb 16, 2010 Buy 3 750 Kumar Amit Non-Qualified Stock Option (right to buy)
Dec 28, 2009 Buy 10 000 Cavalier David Common Stock, par value $0.01 per share
Dec 24, 2009 Buy 714 286 Cavalier David Common Stock, par value $0.01 per share
Dec 24, 2009 Buy 714 286 Cavalier David Common Stock, par value $0.01 per share
Dec 23, 2009 Buy 10 000 Cavalier David Common Stock, par value $0.01 per share
Dec 22, 2009 Buy 10 000 Cavalier David Common Stock, par value $0.01 per share
Dec 21, 2009 Buy 10 000 Cavalier David Common Stock, par value $0.01 per share
Dec 18, 2009 Buy 10 000 Cavalier David Common Stock, par value $0.01 per share
Dec 17, 2009 Buy 20 000 Cavalier David Common Stock, par value $0.01 per share
Dec 10, 2009 Buy 11 250 Suzdak Peter David Non-Qualified Stock Option (right to buy)
JSON CSV
INSIDER POWER
0
Last 100 transactions
Buy: 36 068 220 | Sell: 17 457 775 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 36 068 220 and sold 17 457 775 AOLS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Aeolus Pharmaceuticals, Inc

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and on... AOLS Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT